Showing results (901-910 of 2,442) with videos related to

Sort By:
Pageof 245
Clinical and Translational Science|June 3, 2021
Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetanYing Hong, Tomoko Ishizuka, Akiko Watanabe, et al.
Clinical and Translational Science|June 3, 2021
A first-in-human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamicsEunsol Yang, Hyejung Choi, Jin-Sol Park, et al.
Clinical and Translational Science|June 1, 2022
MicroRNA sequencing in patients with coronary artery disease - considerations for use as biomarker for thrombotic riskChimnonso P Onuoha, Joseph Ipe, Edward Simpson, et al.
Clinical and Translational Science|June 8, 2022
Assessment of drug-drug interaction potential with EDP-305, a farnesoid X receptor agonist, in healthy subjectsAlaa Ahmad, Nathalie Adda
Clinical and Translational Science|June 10, 2022
Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19Sony Tuteja, Zhihong Yu, Otis Wilson, et al.
Clinical and Translational Science|November 24, 2022
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic reviewPhilip G Drennan, Dimitrios Karponis, Duncan Richards, et al.
Clinical and Translational Science|June 30, 2022
The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver diseaseJamie L Ryan, Ashley K Sherman, Daniel E Heble, et al.
Clinical and Translational Science|June 30, 2022
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjectsCourtney Tiffany, Etienne F Dumont, Mohammad Hossain, et al.
Clinical and Translational Science|June 25, 2022
Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass indexErik M Donker, Pierre Bet, Azam Nurmohamed, et al.
Clinical and Translational Science|May 31, 2021
Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuriaYulan Qi, Gina Patel, Joshua Henshaw, et al.
Pageof 245